June 28, 2001New England Journal of Medicine1,565 citationsOpen Access
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events
View Full Paper
Key Points
- This research aims to determine the effectiveness of statin therapy in preventing coronary events based on C-reactive protein levels.
- Measurement of C-reactive protein levels in subjects
- Targeted administration of statin therapy based on C-reactive protein results
- Focus on primary prevention in patients with low lipid levels
- Elevated C-reactive protein levels indicate potential effectiveness of statin therapy for preventing acute coronary events.
- Subjects with low lipid levels but high C-reactive protein experienced better outcomes with statin therapy.
Abstract
Statin therapy may be effective in the primary prevention of coronary events among subjects with relatively low lipid levels but with elevated levels of C-reactive protein.